Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHOP-R followed by PEG-Intron maintenance in indolent NHL
NCT00574730Phase 2Completed
- Sponsor
- University of Nebraska
- Start
- May 2001
- Primary completion
- Aug 2005
- Modality
- Polymer-based Nanoparticles, Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of peginterferon alfa-2b in Indolent Non-Hodgkin Lymphoma (INHL), sponsored by University of Nebraska. Started May 2001; status: completed.
02
Drugs
peginterferon alfa-2b
03
Conditions
Indolent Non-Hodgkin Lymphoma (INHL)
Beyond the preview
Go deeper on NCT00574730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00574730.